Anti-Vegf Agents And The Uses Of These Agents In Eye Diseases

HARUN ÇAKMAK; MÜJDAT KARABULUT; TOLGA KOCATÜRK

Anti-Vegf Agents And The Uses Of These Agents In Eye Diseases

HARUN ÇAKMAK, MÜJDAT KARABULUT, TOLGA KOCATÜRK

HARUN ÇAKMAK: ADNAN MENDERES ÜNİVERSİTESİ
MÜJDAT KARABULUT: ADNAN MENDERES ÜNİVERSİTESİ
TOLGA KOCATÜRK: ADNAN MENDERES ÜNİVERSİTESİ

Year : 2014
Vol : 30
Issue : 2
Page : 93-96

Vascular endothelial growth factor (VEGF), one of the most important mediators of angiogenesis, is upregulated during neovascularization. In fact, anti-VEGF agents have efficacy in the treatment of neovascular age-related macular degeneration, diabetic retinopathy, macular edema, neovascular glaucoma, and corneal neovascularization. In this review, which discusses the biochemistry of VEGF and the use of the anti-VEGF agents in eye diseases.

Cite this Article As : Çakmak H,Karabulut M,Kocatürk T.Anti-VEGF Ajanlar ve Göz Hastalıklarındaki Kullanım Alanları. Selcuk Med J 2014;30(2): 93-96

Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File

Download Citation: BibTeX BibTeX File

Conflict of interest : Yok

This article is published under the CC BY-NC 4.0 license.

Selcuk Medical Journal
2014, Vol. 30 (2)
ISSN: 1017-6616
E-ISSN: 2149-8059

Received : 02.09.2013, Accepted : 02.09.2013, Published Online : 13.08.2018